The overall mortality risk from an open-heart mitral valve surgery is about 11%, which is about one in nine people based on ...
Please provide your email address to receive an email when new articles are posted on . A transseptal mitral valve replacement system was approved for patients unsuitable for surgery or transcatheter ...
Led by Daniel Won, BS (Northwestern Medicine), and published recently in the Annals of Thoracic Surgery, the retrospective ...
Dr. Downs, Gorav Ailawadi, MD, and researchers from a statewide consortium of 18 hospitals in the Virginia Cardiac Surgery Quality Initiative examined records for 1,304 patients who underwent isolated ...
Edwards Lifesciences Corp. received U.S. FDA approval for its Sapien M3 mitral valve replacement system, making it the first transcatheter therapy utilizing a transseptal approach to be indicated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results